Press release
Top Key Players In Ovarian Cancer Market are Allergan plc, Pfizer, Inc., Merck KGaA, AstraZeneca, F. Hoffmann-La Roche AG, Johnson & Johnson, Syndax Pharmaceuticals, Inc., Clovis Oncology
According to the report of Research Cosmos, the Global Ovarian Cancer Market will grow from USD XX Billion in 2015 to USD XX Billion by 2025, at a CAGR of XX% between 2015 and 2025.
Global Ovarian Cancer Market Overview:
Ovarian cancer is a term attributed to the rare type of cancer that occurs in a woman's ovary from different cell types. Ovarian cancer is due to mutagenic changes in DNA. Hereditary genetic mutations are also responsible for ovarian cancer. The risk of developing ovarian cancer is high if a woman has inherited mutations in the BRCA1 and BRCA2 genes. The most common type of ovarian cancer is epithelial ovarian cancer (EOC), which originates in the epithelium of the ovary. Ovarian cancer is considered one of the most common cancers in women. It causes more deaths than any other cancer of the female reproductive system, while it ranks fifth among cancer deaths among women. This type of cancer is rarely diagnosed at an early stage, so it is difficult to treat at an advanced stage.
Browse report brief and TOC @ https://www.researchcosmos.com/reports/ovarian-cancer-in-17-major-markets-forecast-report-2015-2025/579653641
Global Ovarian Cancer Market Drivers and Restraints:
According to estimates by the American Cancer Society, the risk of developing ovarian cancer in a woman is 1 in 75. Ovarian cancer is more frequent in older women. Women in this age group also have the lowest survival rate. Surgical procedures are used for the treatment of early and advanced stages of ovarian cancer. According to estimates by the American Cancer Society, it is expected that about 22,440 women were diagnosed with ovarian cancer alone in the United States, while about 14,080 women died of ovarian cancer in 2017.
Ovarian cancer and its increasing incidence rate is a growing concern throughout the world. Market agents are currently involved in the development of drugs and chemotherapies for the treatment of ovarian cancer. The global market for ovarian cancer drugs is expected to be driven by a large number of treatments at the development stage and by competition among market participants in terms of efficacy and cost of treatment. The expiration of a patent for several leading drugs could also have a potential impact on this market by encouraging the entry of new players. This changing dynamics will have an impact on the ovarian cancer market during the forecast period. Ongoing research and development to provide an effective therapeutic intervention for a multitude of diseases are driving the growth of the ovarian cancer drugs. Several medications for ovarian cancer are in clinical phase and are expected to boost the market in the near future. For example, Merck, Pfizer and Syndax Pharmaceuticals, Inc. have signed an exclusive agreement to study two research agents or drugs for the treatment of ovarian cancer. This study includes Avelumab and entinostat drugs evaluated for their effectiveness as a combined treatment for ovarian cancer.
Request free sample @ https://www.researchcosmos.com/request/ovarian-cancer-in-17-major-markets-forecast-report-2015-20/579653641
Geographic Segmentation:
In terms of region, ovarian cancer can be studied in the regions of Asia Pacific, Europe, Middle East & Africa, North America, and Latin America. The Asia Pacific region is expected to register a large number of cases in the coming years owing to the increasing population and unhealthy lifestyles of the people in the region.
Key Players In Global Ovarian Cancer Market
Companies like Allergan plc, Pfizer, Inc., Merck KGaA, AstraZeneca, F. Hoffmann-La Roche AG, Johnson & Johnson, Syndax Pharmaceuticals, Inc., Clovis Oncology, and others are investing heavily in the research and development and drug discovery processes to created advanced and effective medicines that can prevent the cancers from its root.
About Us:
Research Cosmos is a provider of standard and customized market research, business intelligence and consulting services across more than 100 domains in different industries of the world. We host the trending market reports of the world’s top-notch publishing companies, offering services to a wide range of customers from students to fortune 500 companies and discloses the hidden opportunities in every leading industry of the world.
Contact:
Kevin Stewart
kevin@researchcosmos.com
Global Sales Manager
Research Cosmos
www.researchcosmos.com
+1 888 709 8757
LinkedIn - https://www.linkedin.com/company/market-research-cosmos
Twitter - https://twitter.com/researchcosmos
Google+ - https://plus.google.com/109756852849129986268
Facebook - https://www.facebook.com/researchcosmos/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Top Key Players In Ovarian Cancer Market are Allergan plc, Pfizer, Inc., Merck KGaA, AstraZeneca, F. Hoffmann-La Roche AG, Johnson & Johnson, Syndax Pharmaceuticals, Inc., Clovis Oncology here
News-ID: 1282242 • Views: …
More Releases from Research Cosmos
Mobile Phone Insurance Market Size to Reach USD 32.24 Bn By 2025
The size of the Global mobile phone insurance market is estimated to reach USD 32.24 billion by 2025, growing at a CAGR of 12.5%, as per the recently published report by Research Cosmos. It is worth to claim insurance for mobile phones as we are spending a lot of money on purchasing. The policies include accidental damage, water damage, and screen cracking.
Browse details of the report @ https://www.researchcosmos.com/reports/mobile-phone-insurance-market/199557834
Growing utilization…
Social Employee Recognition Systems Market Predicted to grow at a CAGR of xx By …
Social Employee Recognition Systems Market Analysis Size, Growth rate and Overview:
Social Employee Recognition Systems Market was valued at USD xx million in 2018 and is expected to reach almost USD xx million by the end of 2025, growing at a CAGR of around xx% over the predicted period.
Throughout the world, social employee recognition systems have expanded dramatically to address the need to move away from traditional methods and programs of…
More Releases for Ovarian
Polycystic Ovarian Syndrome Treatment Market Report
The findings reviewed by GME stated that the Global Polycystic Ovarian Syndrome Treatment Market will expand with a CAGR value of 5.2 percent from 2021 to 2026. The rising incidence of PCOS increased understanding among a group of patients, and the growing acceptance of standard treatment boosts the PCOS treatment industry growth over the projected timeframe. Furthermore, the research and development of PCOS are predicted to aid in market growth.
Browse…
How deadly is Ovarian Cancer?
Ovarian Drugs and Treatment Market describes its growth, size, share, Forecast and trends to 2025
Ovarian cancer is a cancer that forms in or on an ovary. It results in abnormal cells that have the ability to invade or spread to other parts of the body.
The global Ovarian Cancer Treatment Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025,…
Polycystic Ovarian Syndrome - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Polycystic Ovarian Syndrome - Pipeline Review, H2 2017 to its growing collection of premium market research reports.
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Polycystic Ovarian Syndrome - Pipeline Review, H2 2017, provides an overview of the Polycystic Ovarian Syndrome (Women's Health) pipeline landscape.
Polycystic ovary syndrome (PCOS) is a common hormonal disorder among women of reproductive age. Symptoms…
Ovarian Cancer Drugs Market Report : 2017
Reports And Markets Publish a New Market Research Report On –"Ovarian Cancer Drugs Market Report : 2017"
Access Full Report With Table Of Contents @ https://www.reportsandmarkets.com/reports/united-states-ovarian-cancer-drugs-market-report-2017-1541150
In this report, the United States Ovarian Cancer Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report splits the United…
Ovarian Cancer - Pipeline Review, H1 2017
Report Hive Market Research Released a New Research Report of 2027 pages on Title " Ovarian Cancer - Pipeline Review, H1 2017 "with detailed Analysis, Forecast and Strategies.
Ovarian Cancer - Pipeline Review, H1 2017
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ovarian Cancer - Pipeline Review, H1 2017, provides an overview of the Ovarian Cancer (Oncology) pipeline landscape.
Ovarian cancer is any cancerous growth that may occur in different…
Ovarian Cancer - Heat Map and Analysis
ReportsWorldwide has announced the addition of a new report title Ovarian Cancer - Heat Map and Analysis to its growing collection of premium market research reports.
Ovarian Cancer (OC) is the fifth most common malignancy diagnosed in women, and the most common gynecological cancer, with an estimated 225,000 new cases diagnosed globally in 2008. Rates are particularly high in developed countries, and especially in Northern Europe. However, substantial improvements in…
